Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions

Hospital end users ranked the CVIS and hemodynamic systems they use, shedding light on their working relationships with IT vendors. 

COVID vaccination updated XBB JN1

CDC: Updated COVID jab significantly reduces odds of infection

The latest COVID-19 vaccine began entering recipients’ bodies last September. Now comes early CDC data supporting the formulation’s general effectiveness.

Thumbnail

Former Pfizer employee convicted of trading on COVID trial info

The statistician pocketed $270,000 in profits after Paxlovid's ability to combat COVID-19 was revealed publicly in a landmark announcement. 

chatgpt for patient questions about radiology

ChatGPT IDs incidental findings on CT images

New research suggests ChatGPT may be able to improve radiology workflows by performing an initial review of CT images.

doctor with overweight patient who may be treated with TAVR or surgery

Are GLP-1 agonists safe? FDA finds no evidence popular weight loss medications cause suicidal thoughts or actions

The popular drugs, originally developed to treat diabetes, are being used more and more in the United States to help obese and overweight patients lose weight.  

artificial intelligence consultation

Imaging specialists partner with Pfizer to deliver AI-powered cardiac amyloidosis evaluations

Improving care for patients with cardiac amyloidosis has emerged as one of the hottest topics in cardiology. Pfizer helped kickstart that trend in 2019 when it gained FDA approval for two separate medications for the rare, but potentially fatal disease. 

Thumbnail

Falls, infections much more likely among Medicare patients treated at private equity-owned hospitals

Private equity is becoming more and more influential in many healthcare specialties, including cardiology. This has prompted increased speculation about the impact such investments may have on patient outcomes.

hospital masking mandates

Hospitals: Maybe don’t trim your PPE stockpiles just yet

Seeking to thwart transmission of communicable respiratory diseases among patients, visitors and staff, hospitals in a handful of states have reinstated masking mandates.

Displaying 153 - 160 of 713

Around the web

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

AI in Healthcare
Healthcare AI regulation needs nuance, balance: Research review

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Radiology Business
Pending radiology bills in Congress and predicting the Trump administration's impact on imaging

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.